Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways.

Molecular Pharmacology
Lina YaoIvan Diamond

Abstract

We found previously that neural responses to ethanol and the dopamine D2 receptor (D2) agonist 2,10,11-trihydroxy-N-propylnorapomorphine hydrobromide (NPA) involve both epsilon protein kinase C (epsilonPKC) and cAMP-dependent protein kinase A (PKA). However, little is known about the mechanism underlying ethanol- and D2-mediated activation of epsilonPKC and the relationship to PKA activation. In the present study, we used a new epsilonPKC antibody, 14E6, that selectively recognized active epsilonPKC when not bound to its anchoring protein epsilonRACK (receptor for activated C-kinase), and PKC isozyme-selective inhibitors and activators to measure PKC translocation and catalytic activity. We show here that ethanol and NPA activated epsilonPKC and induced translocation of both epsilonPKC and its anchoring protein, epsilonRACK to a new cytosolic site. The selective epsilonPKC agonist, pseudo-epsilonRACK, activated epsilonPKC but did not cause translocation of the epsilonPKC/epsilonRACK complex to the cytosol. These data suggest a step-wise activation and translocation of epsilonPKC after NPA or ethanol treatment, where epsilonPKC first translocates and binds to its RACK and subsequently the epsilonPKC/epsilonRACK complex transloca...Continue Reading

References

Aug 1, 1995·Current Opinion in Cell Biology·N R Salama, R W Schekman
May 1, 1993·Trends in Biochemical Sciences·M J Hubbard, P Cohen
Aug 9, 1996·The Journal of Biological Chemistry·P Y YuP A Jose
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·D P DohrmanA S Gordon
Jul 4, 1997·The Journal of Biological Chemistry·M C Faux, J D Scott
Nov 20, 1997·The Journal of Biological Chemistry·M CsukaiD Mochly-Rosen
Feb 12, 1998·Science·T Pawson, J D Scott
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·M MuñizA Velasco
Mar 26, 1998·Alcoholism, Clinical and Experimental Research·K AsaiA S Gordon
Sep 4, 1998·Alcoholism, Clinical and Experimental Research·A S GordonI Diamond
Apr 27, 1999·Nature·T W Robbins, B J Everitt
Oct 23, 2001·Methods in Enzymology·Deborah Schechtman, Daria Mochly-Rosen
Mar 30, 2002·Alcoholism, Clinical and Experimental Research·Douglas P DohrmanIvan Diamond
Aug 7, 2002·The Journal of Biological Chemistry·Ryan A ShanksJames R Goldenring
Nov 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lina YaoIvan Diamond
Feb 6, 2004·The Journal of Biological Chemistry·Miriam C SouroujonDaria Mochly-Rosen
May 6, 2004·Molecular Neurobiology·M Foster Olive, Robert O Messing
Aug 17, 2005·Pharmacology & Therapeutics·P M Newton, R O Messing

❮ Previous
Next ❯

Citations

Mar 3, 2010·The Journal of Biological Chemistry·Caroline N WhiteHelge H Rasmussen
May 13, 2009·The Biochemical Journal·Joydip DasSimon J Slater
Mar 5, 2015·The Journal of Nutritional Biochemistry·Bruno Rodrigo da Silva LippoFabiano Ferreira
Oct 21, 2016·Scientific Reports·Margarida RessurreiçãoAnthony J Walker
Feb 18, 2009·British Journal of Pharmacology·D SachsSh Ferreira
Nov 11, 2008·Annals of the New York Academy of Sciences·Anna M Lee, Robert O Messing
Dec 22, 2017·FEBS Letters·Indu R ChandrashekaranCarsten Schmitz-Peiffer
May 9, 2012·Journal of Neurochemistry·Gustavo P GuerraMaribel A Rubin
Dec 4, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maiti J LommelElisabeth Schaffner-Reckinger
Jun 17, 2011·Alcoholism, Clinical and Experimental Research·Rebecca J HowardR Adron Harris
May 1, 2018·Frontiers in Neuroscience·Rashidi M Pakri MohamedJaya Kumar
Dec 27, 2017·Cell Biochemistry and Function·Xuan ZhangXue-Wu Jiang
Jun 11, 2011·Critical Reviews in Clinical Laboratory Sciences·Silvia Alfonso-Loeches, Consuelo Guerri
May 3, 2021·BMC Cardiovascular Disorders·Muhammad Aetesam-Ur-RahmanStephen P Hoole
Mar 9, 2010·Neuropharmacology·M Katherine KelmGeorge R Breese

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.